Business Of Biotech cover image

Business Of Biotech

Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.

Apr 8, 2024
Jason Gardner, CEO of Ampersand Biomedicines, discusses applying his biotech leadership experience to precision medicine, big data, AI, and company culture. He shares insights on the acquisition strategy, revolutionary drug delivery technology, navigating capital markets, and balancing paranoia with optimism as a CEO.
49:47

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Jason Gardner emphasizes the importance of precision medicine and tech-driven platforms for tailored therapeutics.
  • Strategic approach by Ampersand Biomedicines in leveraging market conditions for optimal impact and driving innovation.

Deep dives

The Strategic Evolution of Ampersand Biomedicence Under Jason Gardner's Leadership

Jason Gardner, the CEO at Ampersand Biomedicence, shares insights on his transition from GSK to biotech, highlighting the science, the impact on patients, and the importance of the team as key motivators. He discusses the motivation to shift focus towards building a company with transformative potential, driven by a passion for science, patient impact, and collaboration with top talent.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode